[ad_1]
Original title: Does it cause a blood clot? Many European countries announced the discontinuation of the new AstraZeneca crown vaccine WHO: Under investigation Source: electronics company
Recently, Denmark, Norway, Iceland, Italy, Austria and other countries have announced the suspension of the new AstraZeneca corona vaccine due to cases of thrombosis among vaccinators. According to a full report from Chinanews.com, after the suspension of the use of AstraZeneca’s coronavirus vaccine in many countries, the British pharmaceutical factory responded at the twelfth local time that its new corona vaccine is safe. On the same day, the World Health Organization stated that it had learned of “specific batches” of the new AstraZeneca corona vaccine that cause thrombosis and is currently evaluating it.
Recently, Denmark, Norway, Iceland, Italy, Austria and other countries have announced the suspension of the new AstraZeneca corona vaccine due to cases of thrombosis among vaccinators.
On the 12th, an AstraZeneca spokesperson responded: “We have analyzed more than 10 million records of safety data. There is no evidence that the vaccine increases pulmonary embolism in any specific age, sex, lot or country, or the risk of Deep vein thrombosis.”
On the same day, the WHO said it learned of the “specific batch” of AstraZeneca’s new corona vaccine that causes thrombosis, but the organization believes that so far no one has died from any new corona vaccine.
Harris, a WHO spokesman, said: “As of March 9, more than 268 million doses of vaccine have been delivered worldwide. According to data reported by governments to WHO, it has not been discovered that the new crown vaccine is the cause of death. ” Harris explained, Thrombosis is very common, so it is unclear if thrombosis will occur after vaccination or if the vaccine is the cause of the thrombus.
He stressed that the risk assessment committee of the EU medical institutions has also determined that the benefits of the vaccine “continue to outweigh the risks.” “The expert group has taken the position that vaccination should continue, and investigations into these thromboembolic events are ongoing.”
Harris said the WHO global advisory committee made up of independent experts is currently evaluating the report on the AstraZeneca vaccine and will announce its findings as soon as possible.
WHO: The new corona virus is expected to have more mutations in the future
According to CCTV News, on March 12 local time, the WHO held a routine press conference for a new coronary pneumonia. Maria van Kokhov, technical director of the WHO health emergency project, said WHO hopes the new corona virus will continue to evolve. there will be more variations in the future. WHO has established a system to track the evolution of the virus. WHO has also cooperated with its regional offices to improve gene sequencing capabilities in various regions to understand the evolution of the new coronavirus and assess the spread of each variant. complete gene sequence of 600,000 new coronaviruses.
Tan Desai also said that more than 335 million doses of the new corona vaccine have been vaccinated worldwide, and no deaths have been found from the new corona vaccine. At least 2.6 million people have died from new coronary pneumonia. The longer it takes to distribute vaccines fairly, the higher the number of deaths.
Tan Desai also pointed out that the emergence of the new mutated coronavirus, the limited supply of new coronavirus vaccines, the late use of new diagnostic tools and oxygen, and the lack of funds to allocate the necessary tools to save lives are the main challenges. in global control of the epidemic.
Furthermore, in response to media reports in some countries restricting the export of new corona vaccines, Mariángela Simão, WHO Deputy Director-General in charge of procurement of medicines and health products, told the press conference that the WHO is very concerned about the targeting of aid to end the new crown The ban on the export of popular products strongly discourages the adoption of such restrictive measures.
